- Report
- April 2023
- 117 Pages
Global
From €4323EUR$4,750USD£3,706GBP
- Report
- April 2023
- 115 Pages
Global
From €4323EUR$4,750USD£3,706GBP
- Report
- April 2023
- 115 Pages
Global
From €4323EUR$4,750USD£3,706GBP
- Report
- April 2023
- 120 Pages
Global
From €4323EUR$4,750USD£3,706GBP
- Report
- August 2022
- 115 Pages
Global
From €4323EUR$4,750USD£3,706GBP
- Report
- August 2022
- 110 Pages
Global
From €4323EUR$4,750USD£3,706GBP
- Report
- January 2022
- 111 Pages
Global
From €4323EUR$4,750USD£3,706GBP
- Report
- January 2022
- 120 Pages
Global
From €4323EUR$4,750USD£3,706GBP
- Report
- January 2022
- 120 Pages
Global
From €4323EUR$4,750USD£3,706GBP
- Report
- September 2023
- 169 Pages
Global
From €3275EUR$3,599USD£2,808GBP
- Report
- December 2023
- 160 Pages
Asia Pacific
From €3275EUR$3,599USD£2,808GBP
- Report
- December 2023
- 158 Pages
Europe, Africa, Middle East Europe, Africa, Middle East
From €3275EUR$3,599USD£2,808GBP
- Report
- December 2023
- 152 Pages
Latin America
From €3275EUR$3,599USD£2,808GBP
- Report
- December 2023
- 155 Pages
North America
From €3275EUR$3,599USD£2,808GBP
- Report
- October 2023
- 188 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- April 2023
- 140 Pages
Global
From €4050EUR$4,450USD£3,472GBP
- Report
- January 2024
- 97 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- January 2024
- 97 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- May 2023
- 83 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- August 2022
- 120 Pages
Global
From €4095EUR$4,500USD£3,511GBP

The Gastrointestinal Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat diseases and disorders of the gastrointestinal tract. These drugs are used to treat conditions such as irritable bowel syndrome, Crohn's disease, ulcerative colitis, and gastroesophageal reflux disease. Commonly prescribed drugs include antacids, proton pump inhibitors, and H2 receptor antagonists.
The Gastrointestinal Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Pfizer, GlaxoSmithKline, Merck & Co., AstraZeneca, and Novartis. These companies are constantly developing new drugs and treatments to meet the needs of patients. Show Less Read more